News & Articles
Great Size ≠ Great Value: How Smaller Outsourcing Partners Benefit Small And Emerging Biotechs
The article highlights the advantages of partnering with smaller outsourcing firms for […]
Read More....What Big CROs Don’t Want You To Know About Staffing Scalability For Phase III Studies
The article addresses the hidden challenges of staffing scalability in Phase III […]
Read More....The Fallacy of the Corporate Memory Concept
The article challenges the concept of “corporate memory” within large CROs, arguing […]
Read More....Do You Take Comfort In Governance Agreements
The article delves into the limitations of governance agreements with large CROs, […]
Read More....Keys to Successful Risk Management in Clinical Trials
The article emphasizes the critical role of comprehensive risk management in clinical […]
Read More....The Great Talent Misconception With Large CROs
The article examines the misconception that large contract research organizations (CROs) offer […]
Read More....Natural History Studies in Gene Therapy Trials: Benefits, Timing and Execution
Natural history studies (NHS) in gene therapy trials are essential for understanding […]
Read More....Is A Multitherapeutic Contract Research Partner The Best Fit For Your Clinical Trial?
You wouldn’t hire a house painter to retouch fine artwork, so why […]
Read More....A Prescription for Success: Treating Deficiencies in Employee Training and Mentoring
When rushed onboarding and inadequate training lead to costly mistakes, companies often […]
Read More....How inSeption Unlocked the Secret to Repeatable, Scalable Low Turnover
This case study explores the evolution of a 10-year partnership and extrapolates […]
Read More....